Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview

Bone Marrow Transplantation volume 25, pages 1269–1278 (2000)Cite this article

Abstract

Mucositis is an inevitable side-effect of the conditioning regimens used for haematopoietic stem cell transplantation. The condition is better referred to as mucosal barrier injury (MBI) since it is primarily the result of toxicity and is a complex and dynamic pathobiological process manifested not only in the mouth but also throughout the entire digestive tract. A model has been proposed for oral MBI and consists of four phases, namely inflammatory, epithelial, ulcerative and healing phases. A variety of factors are involved in causing and modulating MBI including the nature of the conditioning regimen, the elaboration of pro-inflammatory and other cytokines, translocation of the resident microflora and their products, for example, endotoxins across the mucosal barrier, exposure to antimicrobial agents and whether or not the haematopoietic stem cell graft is from a donor. Neutropenic typhlitis is the most severe gastrointestinal manifestation of MBI, but it also influences the occurrence of other major transplant-related complications including acute GVHD, veno-occlusive disease and systemic infections. The pathobiology, clinical counterparts and the means of measuring MBI are discussed together with potential approaches for prevention, amelioration and, perhaps, even cure. Bone Marrow Transplantation (2000) 25, 1269–1278.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Berger AM, Kilroy TJ . Adverse effects of treatment; oral complications. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer; Principles and Practice of Oncology, 5th edn Lippincott-Raven Publishers: Philadelphia 1997 2714–2725

    Google Scholar 

  2. Schubert MM, Williams BE, Lloid ME et al. Clinical assessment scale for the rating of oral mucosal changes associated with bone marrow transplantation. Development of an oral mucositis index Cancer 1992 69: 2469–2477

    CAS  PubMed  Google Scholar 

  3. Woo SB, Sonis ST, Monopoli MM, Sonis AL . A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients Cancer 1993 72: 1612–1617

    CAS  PubMed  Google Scholar 

  4. Parulekar W, Mackenzie R, Bjarnason G, Jordan RC . Scoring oral mucositis Oral Oncol 1998 34: 63–71

    CAS  PubMed  Google Scholar 

  5. Donnelly JP, Muus P, Schattenberg A et al. A scheme for daily monitoring of oral mucositis in allogeneic BMT recipients Bone Marrow Transplant 1992 9: 409–413

    CAS  PubMed  Google Scholar 

  6. Sonis ST . Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity Oral Oncol 1998 34: 39–43

    CAS  PubMed  Google Scholar 

  7. Sleisenger MH, Fordtran JS . Gastrointestinal Disease; Pathophysiology, Diagnosis, Management, 4th edn WB Saunders Company: Philadelphia 1989

    Google Scholar 

  8. Sherman ML, Datta R, Hallahan DE et al. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes J Clin Invest 1991 87: 1794–1797

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Hoffmann B, Hintermeier-Knabe R, Holler E et al. Evidence for induction of TNFa by irradiation and cytotoxic therapy preceding bone marrow transplantation – in vivo and in vitro studies Eur Cytokine Netw 1992 3: 256

    Google Scholar 

  10. Ferrara JL . Cytokine dysregulation as a mechanism of graft versus host disease Curr Opin Immunol 1993 5: 794–799

    CAS  PubMed  Google Scholar 

  11. Sonis ST, Tracey C, Shklar G et al. An animal model for mucositis induced by cancer chemotherapy Oral Surg Oral Med Oral Pathol 1990 69: 437–443

    CAS  PubMed  Google Scholar 

  12. Schwaighofer H, Kernan NA, O'Reilly RJ et al. Serum levels of cytokines and secondary messages after T-cell-depleted and non-T-cell-depleted bone marrow transplantation: influence of conditioning and hematopoietic reconstitution Transplantation 1996 62: 947–953

    CAS  PubMed  Google Scholar 

  13. Hill GR, Crawford JM, Cooke KR et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines Blood 1997 90: 3204–3213

    CAS  PubMed  Google Scholar 

  14. Holler E, Kolb HJ, Moller A et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation Blood 1990 75: 1011–1016

    CAS  PubMed  Google Scholar 

  15. Niederwieser D, Herold M, Woloszczuk W et al. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages Transplantation 1990 50: 620–625

    CAS  PubMed  Google Scholar 

  16. Holler E, Kolb HJ, Mittermuller J et al. Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F) Blood 1995 86: 890–899

    CAS  PubMed  Google Scholar 

  17. Chasty RC, Lamb WR, Gallati H et al. Serum cytokine levels in patients undergoing bone marrow transplantation Bone Marrow Transplant 1993 12: 331–336

    CAS  PubMed  Google Scholar 

  18. Schwaighofer H, Herold M, Schwarz T et al. Serum levels of interleukin 6, interleukin 8, and C-reactive protein after human allogeneic bone marrow transplantation Transplantation 1994 58: 430–436

    CAS  PubMed  Google Scholar 

  19. Adams RB, Planchon SM, Roche JK . IFN-gamma modulation of epithelial barrier function. Time course, reversibility, and site of cytokine binding J Immunol 1993 150: 2356–2363

    CAS  PubMed  Google Scholar 

  20. Austgen TR, Chen MK, Dudrick PS et al. Cytokine regulation of intestinal glutamine utilization Am J Surg 1992 163: 174–179

    CAS  PubMed  Google Scholar 

  21. Marano CW, Lewis SA, Garulacan LA et al. Tumor necrosis factor-alpha increases sodium and chloride conductance across the tight junction of CACO-2 BBE, a human intestinal epithelial cell line J Membr Biol 1998 161: 263–274

    CAS  PubMed  Google Scholar 

  22. Souba WW, Copeland EM . Cytokine modulation of Na(+)-dependent glutamine transport across the brush border membrane of monolayers of human intestinal Caco-2 cells Ann Surg 1992 215: 536–544

    CAS  PubMed  PubMed Central  Google Scholar 

  23. Jarry A, Muzeau F, Laboisse C . Cytokine effects in a human colonic goblet cell line. Cellular damage and its partial prevention by 5 aminosalicylic acid Dig Dis Sci 1992 37: 1170–1178

    CAS  PubMed  Google Scholar 

  24. Fox PC, Grisius MM, Bermudez DK, Sun D . Cytokine mRNA expression in labial salivary glands and cytokine secretion in parotid saliva in Sjogren's syndrome Adv Exp Med Biol 1998 438: 909–915

    CAS  PubMed  Google Scholar 

  25. Xun CQ, Thompson JS, Jennings CD et al. Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice Blood 1994 83: 2360–2367

    CAS  PubMed  Google Scholar 

  26. Goke M, Podolsky DK . Regulation of the mucosal epithelial barrier Baillieres Clin Gastroenterol 1996 10: 393–405

    CAS  PubMed  Google Scholar 

  27. Wright NA . Aspects of the biology of regeneration and repair in the human gastrointestinal tract Philos Trans R Soc Lond B Biol Sci 1998 353: 925–933

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Steel G . Combination of radiotherapy and chemotherapy. In Steel G (ed) Basic Clinical Radiobiology; for Radiation Oncologists Edward Arnold: London 1993 pp 151–162

    Google Scholar 

  29. Muus P, Donnelly P, Schattenberg A et al. Idarubicin-related side effects in recipients of T-cell-depleted allogeneic bone marrow transplants are schedule dependent Semin Oncol 1993 20: (Suppl. 8) 47–52

    CAS  PubMed  Google Scholar 

  30. Shaw MT, Spector MH, Ladman AJ . Effects of cancer, radiotherapy and cytotoxic drugs on intestinal structure and function Cancer Treat Rev 1979 6: 141–151

    CAS  PubMed  Google Scholar 

  31. McNabb PC, Tomasi TB . Host defense mechanisms at mucosal surfaces Annu Rev Microbiol 1981 35: 477–496

    CAS  PubMed  Google Scholar 

  32. Mestecky J, Russell MW, Elson CO . Intestinal IgA: novel views on its function in the defence of the largest mucosal surface Gut 1999 44: 2–5

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Ganz T, Lehrer RI . Defensins Pharmacol Ther 1995 66: 191–205

    CAS  PubMed  Google Scholar 

  34. Garfunkel AA, Tager N, Chausu S et al. Oral complications in bone marrow transplantation patients: recent advances Isr J Med Sci 1994 30: 120–124

    CAS  PubMed  Google Scholar 

  35. Meurman JH, Pyrhonen S, Teerenhovi L, Lindqvist C . Oral sources of septicaemia in patients with malignancies Oral Oncol 1997 33: 389–397

    CAS  PubMed  Google Scholar 

  36. Ruescher TJ, Sodeifi A, Scrivani SJ et al. The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies Cancer 1998 82: 2275–2281

    CAS  PubMed  Google Scholar 

  37. Donnelly JP, Dompeling EC, Meis JF, de-Pauw BE . Bacteremia due to oral viridans streptococci in neutropenic patients with cancer: cytostatics are a more important risk factor than antibacterial prophylaxis Clin Infect Dis 1995 20: 469–470

    CAS  PubMed  Google Scholar 

  38. Elting LS, Bodey GP, Keefe BH . Septicemia and shock syndrome due to viridans streptococci: a case-control study of predisposing factors Clin Infect Dis 1992 14: 1201–1207

    CAS  PubMed  Google Scholar 

  39. Lucas VS, Beighton D, Roberts GJ, Challacombe SJ . Changes in the oral streptococcal flora of children undergoing allogeneic bone marrow transplantation J Infect 1997 35: 135–141

    CAS  PubMed  Google Scholar 

  40. Dompeling EC, Donnelly JP, Raemaekers JM, de-Pauw BE . Pre-emptive administration of corticosteroids prevents the development of ARDS associated with Streptococcus mitis bacteremia following chemotherapy with high-dose cytarabine Ann Hematol 1994 69: 69–71

    CAS  PubMed  Google Scholar 

  41. Hall G, Heimdahl A, Nord CE . Bacteremia after oral surgery and antibiotic prophylaxis for endocarditis Clin Infect Dis 1999 29: 1–8

    CAS  PubMed  Google Scholar 

  42. Berg RD . Probiotics, prebiotics or ‘conbiotics’? Trends Microbiol 1998 6: 89–92

    CAS  PubMed  Google Scholar 

  43. Gibson GR, Roberfroid MB . Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics J Nutr 1995 125: 1401–1412

    CAS  PubMed  Google Scholar 

  44. Ferry DM, Butt TJ, Broom MF et al. Bacterial chemotactic oligopeptides and the intestinal mucosal barrier Gastroenterology 1989 97: 61–67

    CAS  PubMed  Google Scholar 

  45. Tancrede CH, Andremont AO . Bacterial translocation and gram-negative bacteremia in patients with hematological malignancies J Infect Dis 1985 152: 99–103

    CAS  PubMed  Google Scholar 

  46. Guzman SG, Bonsack M, Liberty J, Delaney JP . Abdominal radiation causes bacterial translocation J Surg Res 1989 46: 104–107

    Google Scholar 

  47. Berg RD . Bacterial translocation from the gastrointestinal tracts of mice receiving immunosuppressive chemotherapeutic agents Curr Microbiol 1983 8: 285–292

    CAS  Google Scholar 

  48. Wells CL, Maddaus MA, Simmons RL . Proposed mechanisms for the translocation of intestinal bacteria Rev Infect Dis 1988 10: 958–979

    CAS  PubMed  Google Scholar 

  49. Alexander JW, Boyce ST, Babcock GF et al. The process of microbial translocation Ann Surg 1990 212: 496–510

    CAS  PubMed  PubMed Central  Google Scholar 

  50. van-Leeuwen PA, Boermeester MA, Houdijk AP et al. Clinical significance of translocation Gut 1994 35: (Suppl.) S28–S34

    CAS  PubMed  PubMed Central  Google Scholar 

  51. O'Dwyer ST, Michie HR, Ziegler TR et al. A single dose of endotoxin increases intestinal permeability in healthy humans Arch Surg 1988 123: 1459–1464

    CAS  PubMed  Google Scholar 

  52. Nestel FP, Price KS, Seemayer TA, Lapp WS . Macrophage priming and lipopolysaccharide-triggered release of tumor necrosis factor alpha during graft-versus-host disease J Exp Med 1992 175: 405–413

    CAS  PubMed  Google Scholar 

  53. Jackson SK, Parton J, Barnes RA et al. Effect of IgM-enriched intravenous immunoglobulin (Pentaglobin) on endotoxaemia and anti-endotoxin antibodies in bone marrow transplantation Eur J Clin Invest 1993 23: 540–545

    CAS  PubMed  Google Scholar 

  54. Schrijver IA, Melief MJ, Eulderink F et al. Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells J Infect Dis 1999 179: 1459–1468

    CAS  PubMed  Google Scholar 

  55. Gomez L, Martino R, Rolston KV . Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases Clin Infect Dis 1998 27: 695–699

    CAS  PubMed  Google Scholar 

  56. Gorbach SL . Editorial response: neutropenic enterocolitis Clin Infect Dis 1998 27: 700–701

    CAS  PubMed  Google Scholar 

  57. Pouwels MJ, Donnelly JP, Raemaekers JM et al. Clostridium septicum sepsis and neutropenic enterocolitis in a patient treated with intensive chemotherapy for acute myeloid leukemia Ann Hematol 1997 74: 143–147

    CAS  PubMed  Google Scholar 

  58. Yuen KY, Woo PCY, Liang RHS et al. Clinical significance of alimentary tract microbes in bone marrow transplant recipients Diagn Microbiol Infect Dis 1998 30: 75–81

    CAS  PubMed  Google Scholar 

  59. Berkowitz RJ, Strandjord S, Jones P et al. Stomatologic complications of bone marrow transplantation in a pediatric population Pediatr Dent 1987 9: 105–110

    CAS  PubMed  Google Scholar 

  60. McDonald GB, Shulman HM, Sullivan KM, Spencer GD . Intestinal and hepatic complications of human bone marrow transplantation. Part II Gastroenterology 1986 90: 770–784

    CAS  PubMed  Google Scholar 

  61. Lacy ER . Epithelial restitution in the gastrointestinal tract J Clin Gastroenterol 1988 10: (Suppl. 1) S72–S77

    PubMed  Google Scholar 

  62. Moss SF, Wright NA . Molecular aspects of mucosal repair: a summary (comment) J Biol Med 1996 69: 155–158

    CAS  Google Scholar 

  63. Modlin IM, Poulsom R . Trefoil peptides: mitogens, motogens, or mirages? J Clin Gastroenterol 1997 25: (Suppl. 1) S94–S100

    PubMed  Google Scholar 

  64. Podolsky DK . Healing the epithelium: solving the problem from two sides J Gastroenterol 1997 32: 122–126

    CAS  PubMed  Google Scholar 

  65. Imamura M, Hashino S, Kobayashi H et al. Serum cytokine levels in bone marrow transplantation: synergistic interaction of interleukin-6, interferon-gamma, and tumor necrosisfactor-alpha in graft-versus-host disease Bone MarrowTransplant 1994 13: 745–751

    CAS  Google Scholar 

  66. Pollard M, Chang CF, Srivastava KK . The role of microflora in development of graft-versus-host disease Transplant Proc 1976 8: 533–536

    CAS  PubMed  Google Scholar 

  67. van-Bekkum DW, Knaan S . Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction J Natl Cancer Inst 1977 58: 787–790

    CAS  PubMed  Google Scholar 

  68. Beelen DW, Elmaagacil A, Müller K-D et al. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomised trial Blood 1999 93: 3267–3275

    CAS  PubMed  Google Scholar 

  69. Travis S, Menzies I . Intestinal permeability: functional assessment and significance Clin Sci Colch 1992 82: 471–488

    CAS  PubMed  Google Scholar 

  70. Johansson JE, Ekman T . Gastro-intestinal toxicity related to bone marrow transplantation: disruption of the intestinal barrier precedes clinical findings Bone Marrow Transplant 1997 19: 921–925

    CAS  PubMed  Google Scholar 

  71. Selby P, McElwain TJ, Crofts M et al. 51Cr-EDTA test for intestinal permeability Lancet 1984 2: 38–39

    CAS  PubMed  Google Scholar 

  72. Rohrbaugh TM, Anolik R, August CS et al. Absorption of oral aminoglycosides following bone marrow transplantation Cancer 1984 53: 1502–1506

    CAS  PubMed  Google Scholar 

  73. Ranaldi G, Islam K, Sambuy Y . Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents Antimicrob Agents Chemother 1992 36: 1374–1381

    CAS  PubMed  PubMed Central  Google Scholar 

  74. Meunier V, Bourrie M, Berger Y, Fabre G . The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications Cell Biol Toxicol 1995 11: 187–194

    CAS  PubMed  Google Scholar 

  75. Uil JJ, van-Elburg RM, van-Overbeek FM et al. Clinical implications of the sugar absorption test: intestinal permeability test to assess mucosal barrier function Scand J Gastroenterol 1997 223: (Suppl.) 20–28

    Google Scholar 

  76. Parrilli G, Iaffaioli RV, Capuano G et al. Changes in intestinal permeability to lactulose induced by cytotoxic chemotherapy Cancer Treat Rep 1982 66: 1435–1436

    CAS  PubMed  Google Scholar 

  77. Parrilli G, Iaffaioli RV, Martorano M et al. Effects of anthracycline therapy on intestinal absorption in patients with advanced breast cancer Cancer Res 1989 49: 3689–3691

    CAS  PubMed  Google Scholar 

  78. Keefe DM, Cummins AG, Dale BM et al. Effect of high-dose chemotherapy on intestinal permeability in humans Clin Sci Colch 1997 92: 385–389

    CAS  PubMed  Google Scholar 

  79. Fegan C, Poynton CH, Whittaker JA . The gut mucosal barrier in bone marrow transplantation Bone Marrow Transplant 1990 5: 373–377

    CAS  PubMed  Google Scholar 

  80. Bow EJ, Loewen R, Cheang MS, Schacter B . Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen Clin Infect Dis 1995 21: 361–369

    CAS  PubMed  Google Scholar 

  81. Bow EJ, Loewen R, Cheang MS, Shore TB et al. Cytotoxic therapy-induced D-xylose malabsorption and invasive infection during remission-induction therapy for acute myeloid leukemia in adults J Clin Oncol 1997 15: 2254–2261

    CAS  PubMed  Google Scholar 

  82. Sonis ST, Eilers JP, Epstein JB et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy Cancer 1999 85: 2103–2113

    CAS  PubMed  Google Scholar 

  83. Saiki T, Mitsuyama K, Toyonaga A et al. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease Scand J Gastroenterol 1998 33: 616–622

    CAS  PubMed  Google Scholar 

  84. Wymenga AN, van-der-Graaf WT, Spijkervet FL et al. A new in vitro assay for quantitation of chemotherapy-induced mucositis Br J Cancer 1997 76: 1062–1066

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Adkins D, Goodgold H, Hendershott L et al. Indium-labeled white blood cells apheresed from donors receiving G-CSF localize to sites of inflammation when infused into allogeneic bone marrow transplant recipients Bone Marrow Transplant 1997 19: 809–812

    CAS  PubMed  Google Scholar 

  86. Deitch EA . Bacterial translocation: the influence of dietary variables Gut 1994 35: (Suppl.) S23–S27

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Papadopoulou A, Williams MD, Darbyshire PJ, Booth IW . Nutritional support in children undergoing bone marrow transplantation Clin Nutr 1998 17: 57–63

    CAS  PubMed  Google Scholar 

  88. Papadopoulou A, MacDonald A, Williams MD et al. Enteral nutrition after bone marrow transplantation Arch Dis Child 1997 77: 131–136

    CAS  PubMed  PubMed Central  Google Scholar 

  89. Ramos MG, Bambirra EA, Cara DC et al. Oral administration of short-chain fatty acids reduces the intestinal mucositis caused by treatment with Ara-C in mice fed commercial or elemental diets Nutr Cancer 1997 28: 212–217

    CAS  PubMed  Google Scholar 

  90. Illig KA, Ryan CK, Hardy DJ et al. Total parenteral nutrition-induced changes in gut mucosal function: atrophy alone is not the issue Surgery 1992 112: 631–637

    CAS  PubMed  Google Scholar 

  91. Weisdorf SA, Lysne J, Wind D et al. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation Transplantation 1987 43: 833–838

    CAS  PubMed  Google Scholar 

  92. Iestra JA, Fibbe WE, Zwinderman AH et al. Parenteral nutrition following intensive cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies Bone Marrow Transplant 1999 23: 933–939

    CAS  PubMed  Google Scholar 

  93. Lacey JM, Wilmore DW . Is glutamine a conditionally essential amino acid? Nutr Rev 1990 48: 297–309

    CAS  PubMed  Google Scholar 

  94. Karatzas T, Scopa S, Tsoni I et al. Effect of glutamine on intestinal mucosal integrity and bacterial translocation after abdominal radiation Clin Nutr 1991 10: 199–205

    CAS  PubMed  Google Scholar 

  95. Klimberg VS, Souba WW, Dolson DJ et al. Prophylactic glutamine protects the intestinal mucosa from radiation injury Cancer 1990 66: 62–68

    CAS  PubMed  Google Scholar 

  96. Klimberg VS, Nwokedi E, Hutchins LF et al. Glutamine facilitates chemotherapy while reducing toxicity J Paren Ent Nutr 1992 16: (Suppl.) 83S–87S

    CAS  Google Scholar 

  97. Anderson PM, Ramsay NKC, Shu XO et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation Bone Marrow Transplant 1998 22: 339–344

    CAS  PubMed  Google Scholar 

  98. Anderson PM, Schroeder G, Skubitz KM . Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy Cancer 1998 83: 1433–1439

    CAS  PubMed  Google Scholar 

  99. Muscaritoli M, Micozzi A, Conversano L et al. Oral glutamine in the prevention of chemotherapy-induced gastrointestinal toxicity Eur J Cancer 1997 33: 319–320

    CAS  PubMed  Google Scholar 

  100. Brown SA, Goringe A, Fegan C et al. Parenteral glutamine protects hepatic function during bone marrow transplantation Bone Marrow Transplant 1998 22: 281–284

    CAS  PubMed  Google Scholar 

  101. Ziegler TR, Young LS, Benfell K et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study Ann Intern Med 1992 116: 821–828

    CAS  PubMed  Google Scholar 

  102. Schloerb PR, Skikne BS . Oral and parenteral glutamine in bone marrow transplantation: A randomized, double-blind study JPEN 1999 23: 117–122

    CAS  Google Scholar 

  103. van-Zaanen HC, van-der-Lelie H, Timmer JG et al. Parenteral glutamine dipeptide supplementation does not ameliorate chemotherapy-induced toxicity Cancer 1994 74: 2879–2884

    CAS  PubMed  Google Scholar 

  104. Franzen L, Henriksson R, Littbrand B, Zackrisson B . Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study Acta Oncol 1995 34: 219–223

    CAS  PubMed  Google Scholar 

  105. Makkonen TA, Bostrom P, Vilja P, Joensuu H . Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study Int J Radiat Oncol Biol Phys 1994 30: 177–182

    CAS  PubMed  Google Scholar 

  106. Barker G, Loftus L, Cuddy P, Barker B . The effects of sucralfate suspension and diphenhydramine syrup plus kaolin-pectin on radiotherapy-induced mucositis Oral Surg Oral Med Oral Pathol 1991 71: 288–293

    CAS  PubMed  Google Scholar 

  107. Sonis ST, Van-Vugt AG, Brien JP et al. Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis Oral Oncol 1997 33: 47–54

    CAS  PubMed  Google Scholar 

  108. Sonis ST, Costa-JW J, Evitts SM et al. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive cancer chemotherapy Oral Surg Oral Med Oral Pathol 1992 74: 749–755

    CAS  PubMed  Google Scholar 

  109. Gordon B, Spadinger A, Hodges E et al. Effect of granulocyte–macrophage colony-stimulating factor on oral mucositis after hematopoietic stem-cell transplantation J Clin Oncol 1994 12: 1917–1922

    CAS  PubMed  Google Scholar 

  110. Ibrahim EM, al-Mulhim FA . Effect of granulocyte–macrophage colony-stimulating factor on chemotherapy-induced oral mucositis in non-neutropenic cancer patients Med Oncol 1997 14: 47–51

    CAS  PubMed  Google Scholar 

  111. Lieschke GJ, Ramenghi U, O'Connor MP et al. Studies of oral neutrophil levels in patients receiving G-CSF after autologous marrow transplantation Br J Haematol 1992 82: 589–595

    CAS  PubMed  Google Scholar 

  112. Keith-JC J, Albert L, Sonis ST et al. IL-11, a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology Stem Cells 1994 12: (Suppl. 1) 79–89

    PubMed  Google Scholar 

  113. Sonis ST, Van-Vugt AG, McDonald J et al. Mitigating effects of interleukin 11 on consecutive courses of 5-fluorouracil-induced ulcerative mucositis in hamsters Cytokine 1997 9: 605–612

    CAS  PubMed  Google Scholar 

  114. Danilenko DM . Preclinical and early clinical development of keratinocyte growth factor, an epithelial-specific tissue growth factor Toxicol Pathol 1999 27: 64–71

    CAS  PubMed  Google Scholar 

  115. Reilly RM, Domingo R, Sandhu J . Oral delivery of antibodies. Future pharmacokinetic trends Clin Pharmacokinet 1997 32: 313–323

    CAS  PubMed  Google Scholar 

  116. Barker GJ . Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation Support Care Cancer 1999 7: 17–20

    CAS  PubMed  Google Scholar 

  117. Bondi E, Baroni C, Prete A et al. Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation Oral Oncol 1997 33: 322–326

    CAS  PubMed  Google Scholar 

  118. Ferretti GA, Ash RC, Brown AT et al. Chlorhexidine for prophylaxis against oral infections and associated complications in patients receiving bone marrow transplants J Am Dent Assoc 1987 114: 461–467

    CAS  PubMed  Google Scholar 

  119. Foote RL, Loprinzi CL, Frank AR et al. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis J Clin Oncol 1994 12: 2630–2633

    CAS  PubMed  Google Scholar 

  120. Weisdorf DJ, Bostrom B, Raether D et al. Oropharyngeal mucositis complicating bone marrow transplantation: prognostic factors and the effect of chlorhexidine mouth rinse Bone Marrow Transplant 1989 4: 89–95

    CAS  PubMed  Google Scholar 

  121. Spijkervet FK, van-Saene HK, van-Saene JJ et al. Mucositis prevention by selective elimination of oral flora in irradiated head and neck cancer patients J Oral Pathol Med 1990 19: 486–489

    CAS  PubMed  Google Scholar 

  122. Salminen S, Isolauri E, Salminen E . Clinical uses of probiotics for stabilizing the gut mucosal barrier: successful strains and future challenges Antonie Van Leeuwenhoek 1996 70: 347–358

    CAS  PubMed  Google Scholar 

  123. Johansson JE, Ekman T . Gut mucosa barrier preservation by orally administered IgA-IgG to patients undergoing bone marrow transplantation: a randomised pilot study BoneMarrow Transplant 1999 24: 35–39

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, University Medical Center St Radboud, Nijmegen, The Netherlands

    NMA Blijlevens, JP Donnelly & BE De Pauw

Authors
  1. NMA Blijlevens
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. JP Donnelly
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. BE De Pauw
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Blijlevens, N., Donnelly, J. & De Pauw, B. Mucosal barrier injury: biology, pathology, clinical counterparts and consequences of intensive treatment for haematological malignancy: an overview. Bone Marrow Transplant 25, 1269–1278 (2000). https://doi.org/10.1038/sj.bmt.1702447

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702447

Keywords

This article is cited by

Search

Advanced search

Quick links